1. Home
  2. BLDP vs EVO Comparison

BLDP vs EVO Comparison

Compare BLDP & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ballard Power Systems Inc.

BLDP

Ballard Power Systems Inc.

HOLD

Current Price

$2.16

Market Cap

657.3M

Sector

Energy

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.58

Market Cap

778.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLDP
EVO
Founded
1979
1993
Country
Canada
Germany
Employees
492
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
657.3M
778.3M
IPO Year
2009
2007

Fundamental Metrics

Financial Performance
Metric
BLDP
EVO
Price
$2.16
$1.58
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$2.34
$7.00
AVG Volume (30 Days)
2.5M
41.4K
Earning Date
05-05-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.53
$1.37
Revenue Next Year
$18.02
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.93
$1.60
52 Week High
$6.57
$4.27

Technical Indicators

Market Signals
Indicator
BLDP
EVO
Relative Strength Index (RSI) 35.94 28.43
Support Level $1.98 N/A
Resistance Level $2.22 $1.97
Average True Range (ATR) 0.09 0.05
MACD 0.01 -0.01
Stochastic Oscillator 18.09 2.70

Price Performance

Historical Comparison
BLDP
EVO

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from United States followed by Poland, Canada, and other countries.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: